CLOV
Price
$4.38
Change
+$0.15 (+3.55%)
Updated
Oct 2 closing price
Capitalization
2.3B
38 days until earnings call
Intraday BUY SELL Signals
HUM
Price
$388.22
Change
+$8.54 (+2.25%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
46.79B
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLOV vs HUM

CLOV vs HUM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CLOV vs. HUM commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLOV is a Hold and HUM is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
CLOV vs HUM: Fundamental Ratings
CLOV
HUM
OUTLOOK RATING
1..100
7573
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
9
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9298
PRICE GROWTH RATING
1..100
3737
P/E GROWTH RATING
1..100
1008
SEASONALITY SCORE
1..100
n/a33

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HUM's Valuation (9) in the Managed Health Care industry is in the same range as CLOV (36) in the null industry. This means that HUM’s stock grew similarly to CLOV’s over the last 12 months.

HUM's Profit vs Risk Rating (100) in the Managed Health Care industry is in the same range as CLOV (100) in the null industry. This means that HUM’s stock grew similarly to CLOV’s over the last 12 months.

CLOV's SMR Rating (92) in the null industry is in the same range as HUM (98) in the Managed Health Care industry. This means that CLOV’s stock grew similarly to HUM’s over the last 12 months.

CLOV's Price Growth Rating (37) in the null industry is in the same range as HUM (37) in the Managed Health Care industry. This means that CLOV’s stock grew similarly to HUM’s over the last 12 months.

HUM's P/E Growth Rating (8) in the Managed Health Care industry is significantly better than the same rating for CLOV (100) in the null industry. This means that HUM’s stock grew significantly faster than CLOV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLOVHUM
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 8 days ago
63%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
70%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (CLOV: $4.38 vs. HUM: $388.36)
Brand notoriety: CLOV: Not notable vs. HUM: Notable
Both companies represent the Managed Health Care industry
Current volume relative to the 65-day Moving Average: CLOV: 105% vs. HUM: 65%
Market capitalization -- CLOV: $2.3B vs. HUM: $46.79B
CLOV [@Managed Health Care] is valued at $2.3B. HUM’s [@Managed Health Care] market capitalization is $46.79B. The market cap for tickers in the [@Managed Health Care] industry ranges from $335.99K to $339.14B. The average market capitalization across the [@Managed Health Care] industry is $64.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLOV’s FA Score shows that 0 FA rating(s) are green while HUM’s FA Score has 2 green FA rating(s).

  • CLOV’s FA Score: 0 green, 5 red.
  • HUM’s FA Score: 2 green, 3 red.
According to our system of comparison, HUM is a better buy in the long-term than CLOV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLOV’s TA Score shows that 4 TA indicator(s) are bullish while HUM’s TA Score has 6 bullish TA indicator(s).

  • CLOV’s TA Score: 4 bullish, 6 bearish.
  • HUM’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, HUM is a better buy in the short-term than CLOV.

Price Growth

CLOV (@Managed Health Care) experienced а -2.45% price change this week, while HUM (@Managed Health Care) price change was -2.40% for the same time period.

The average weekly price growth across all stocks in the @Managed Health Care industry was -0.95%. For the same industry, the average monthly price growth was -7.58%, and the average quarterly price growth was +57.17%.

Reported Earning Dates

CLOV is expected to report earnings on Nov 09, 2026.

HUM is expected to report earnings on Nov 06, 2026.

Industries' Descriptions

@Managed Health Care (-0.95% weekly)

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

View a ticker or compare two or three
CLOV
Daily Signal:
Gain/Loss:
HUM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SBLK30.431.07
+3.64%
Star Bulk Carriers Corp
FE43.390.06
+0.14%
FirstEnergy Corp
NGVC30.480.02
+0.07%
Natural Grocers BY Vitamin Cottage
UNCY4.55-0.14
-3.09%
Unicycive Therapeutics Inc
CLGN3.57-0.13
-3.51%
CollPlant Biotechnologies Ltd.

CLOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLOV has been loosely correlated with HUM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CLOV jumps, then HUM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLOV
1D Price
Change %
CLOV100%
-1.86%
HUM - CLOV
39%
Loosely correlated
-0.50%
ALHC - CLOV
37%
Loosely correlated
-5.15%
OSCR - CLOV
31%
Poorly correlated
-3.05%
UNH - CLOV
30%
Poorly correlated
-0.51%
CI - CLOV
24%
Poorly correlated
-1.42%
More

HUM and

Correlation & Price change

A.I.dvisor indicates that over the last year, HUM has been loosely correlated with UNH. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if HUM jumps, then UNH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HUM
1D Price
Change %
HUM100%
-0.50%
UNH - HUM
66%
Loosely correlated
-0.51%
ELV - HUM
56%
Loosely correlated
-1.84%
CVS - HUM
53%
Loosely correlated
-0.57%
CNC - HUM
49%
Loosely correlated
-1.82%
OSCR - HUM
40%
Loosely correlated
-3.05%
More